Joshua Chu-Tan


Joshua Chu-Tan is a postdoctoral fellow and lecturer in medical physiology and neuroscience at the Australian National University in Canberra, Australia. 

Josh’s research at the ANU’s John Curtin School of Medical Research focuses on the role of microRNA and their potential use as novel gene therapeutics for progressive retinal degenerations, with a specific focus on age-related macular degeneration (AMD), the leading cause of blindness in the developed world. His work in the field has been published in top-ranked ophthalmology and vision science journals and he also served as intern editor, blog writer, and advisor at world-leading academic publishing company, Springer Nature.

Josh’s passion and strong track record in science communication has earned him numerous awards for conference presentations and public speaking events and competitions, including first prize at the Asia-Pacific 3 Minute Thesis, and  A.T. Kearney Scholar/Finalist for Young Innovator of the Year at the prestigious Falling Walls Conference and Lab in Berlin, Germany.